Skip to main content
    M

    MEDIFAST INC (MED)

    Official site

    CONSUMER CYCLICAL • PERSONAL SERVICES • NYSE

    $12.52
    -0.45 (-3.47%)

    Market Cap: $145.04M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    MEDIFAST INC (MED) Financials: Revenue, Profit and Cash Flow

    Updated Oct 26, 2026. Financial statements from company filings, amounts in US dollars.

    MEDIFAST INC reported revenue of $385.79M for the fiscal year ended Dec 31, 2025, down 36.0% from the year before. That year, net income was -$18.67M with a net margin of -4.8%, operating cash flow was $6.86M and free cash flow was $1.25M. The quarter ended Sep 30, 2026 had revenue of $72.05M and net income of -$17.51M.

    Revenue and Margins

    The operating margin was -3.7% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $274.53M, a compound annual rate of 3.9%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$385.79M-36.0%71.3%-3.7%-4.8%
    Dec 2024$602.46M-43.8%73.8%0.5%0.3%
    Dec 2023$1.07B-32.9%72.4%11.8%9.3%
    Dec 2022$1.60B+4.8%71.3%11.6%9.0%
    Dec 2021$1.53B+63.2%73.9%14.2%10.7%
    Dec 2020$934.84M+31.0%74.6%14.4%11.0%
    Dec 2019$713.67M+42.4%75.2%12.8%10.9%
    Dec 2018$501.00M+66.1%75.8%13.8%11.1%
    Dec 2017$301.56M+9.8%75.5%13.1%9.2%
    Dec 2016$274.53MN/A74.9%9.8%6.5%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$385.79M$602.46M$1.07B$1.60B$1.53B$934.84M$713.67M$501.00M$301.56M$274.53M
    Cost of revenue$110.60M$157.84M$296.20M$458.16M$398.49M$237.03M$176.81M$121.10M$73.75M$68.87M
    Gross profit$275.19M$444.62M$775.85M$1.14B$1.13B$697.82M$536.86M$379.90M$227.81M$205.66M
    Operating income-$14.21M$2.88M$126.40M$184.81M$216.24M$134.16M$91.04M$69.06M$39.63M$26.86M
    Net income-$18.67M$2.09M$99.42M$143.57M$164.03M$102.86M$77.92M$55.79M$27.72M$17.84M
    EBITDA$2.42M$10.89M$139.25M$195.75M$223.26M$138.66M$96.15M$74.25M$44.68M$32.67M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$72.05M$76.38M$76.04M$75.10M$89.41M$105.56M$115.73M$119.00M$140.16M$168.56M$174.74M$191.01M
    Gross profit$50.04M$53.40M$51.76M$52.14M$62.16M$76.64M$84.25M$88.22M$105.67M$123.44M$127.29M$141.37M
    Operating income-$19.36M-$4.33M-$3.29M-$7.80M-$4.08M-$1.07M-$1.26M$708.00K$2.11M-$7.88M$7.94M$8.68M
    Net income-$17.51M-$3.10M-$2.12M-$18.12M-$2.26M$2.48M-$772.00K$800.00K$1.13M-$8.15M$8.32M$6.04M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $4.60M by $84.70M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$247.97M$284.21M$309.91M$316.21M$398.33M$276.08M$194.65M$169.43M$145.93M$121.22M
    Current assets$201.68M$214.40M$224.03M$222.78M$306.87M$234.31M$154.15M$145.52M$125.20M$101.30M
    Cash and equivalents$89.30M$90.93M$94.44M$87.69M$104.18M$163.72M$76.97M$81.36M$75.08M$52.44M
    Total liabilities$49.05M$74.10M$108.43M$161.17M$195.85M$118.84M$89.82M$60.32M$37.35M$25.20M
    Short-term debt$4.60M$6.18M$5.88M$5.78M$6.52M$3.67M$3.17M$0$0$0
    Long-term debtN/AN/AN/AN/AN/AN/AN/AN/A$0$779.00K
    Shareholder equity$198.92M$210.11M$201.48M$155.04M$202.47M$157.25M$104.83M$109.11M$108.58M$96.02M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$239.76M$260.40M$252.05M$257.01M$268.21M$269.33M$280.01M$284.21M$291.24M$293.53M$302.76M$309.91M
    Total liabilities$59.49M$64.02M$54.37M$58.09M$53.50M$53.33M$69.05M$74.10M$83.89M$88.25M$91.80M$108.43M
    Cash and equivalents$58.37M$71.91M$71.53M$89.30M$99.53M$101.69M$91.72M$90.93M$115.31M$108.02M$97.47M$94.44M
    Shareholder equity$180.28M$196.38M$197.68M$198.92M$214.71M$216.00M$210.96M$210.11M$207.34M$205.28M$210.96M$201.48M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 18.2% of operating cash flow. Dividends and share repurchases together came to 45.1% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$6.86M$24.48M$147.66M$194.57M$94.55M$145.20M$84.26M$60.82M$43.24M$25.35M
    Capital expenditures$5.61M$7.45M$6.48M$16.68M$34.21M$5.89M$10.06M$4.94M$3.24M$2.88M
    Free cash flow$1.25M$17.02M$141.17M$177.89M$60.34M$139.31M$74.20M$55.88M$39.99M$22.47M
    Dividends paid$195.00K$715.00K$73.02M$71.62M$63.86M$53.19M$35.40M$23.16M$15.39M$11.89M
    Share repurchases$369.00K$836.00K$6.96M$127.96M$62.09M$5.55M$47.21M$30.71M$2.54M$1.34M
    Investing cash flow-$7.93M-$26.52M-$61.05M-$11.41M-$29.06M-$1.28M-$6.33M-$1.20M-$3.16M-$2.04M
    Financing cash flow-$564.00K-$1.51M-$79.79M-$199.58M-$125.13M-$57.14M-$82.32M-$53.33M-$17.36M-$12.92M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$3.29M$1.70M$260.00K-$5.28M$12.11M-$3.38M$3.41M-$4.95M$9.07M$13.07M$7.28M$10.52M
    Capital expenditures$427.00K$969.00K$1.10M$1.35M$1.36M$1.38M$1.52M$2.29M$1.39M$1.94M$1.84M$946.00K
    Free cash flow$2.87M$728.00K-$836.00K-$6.63M$10.75M-$4.76M$1.88M-$7.23M$7.68M$11.13M$5.44M$9.58M
    Last 12 quarters

    Frequently Asked Questions About MED

    What is MEDIFAST INC's annual revenue?

    MEDIFAST INC reported revenue of $385.79M for the fiscal year ended Dec 31, 2025.

    How fast is MEDIFAST INC's revenue growing?

    Revenue was down 36.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -37.7%.

    Is MEDIFAST INC profitable?

    No. MEDIFAST INC reported net income of -$18.67M for the fiscal year ended Dec 31, 2025, with a net margin of -4.8%.

    How much free cash flow does MED generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $6.86M minus capital expenditures of $5.61M produced free cash flow of $1.25M.

    How much debt does MEDIFAST INC have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $4.60M and cash and equivalents of $89.30M.